[ALNY] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
03-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -15.47%
YoY- -35.52%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 70,061 2,069 17,096 13,651 6,324 10,972 8,991 40.78%
PBT -208,929 -244,837 -122,937 -104,071 -76,792 -43,922 -31,956 36.72%
Tax -394 445 -3,296 -2,204 -1,610 67 -2,270 -25.30%
NP -208,535 -245,282 -122,937 -104,071 -76,792 -43,989 -29,686 38.36%
Tax Rate - - - - - - - -
Total Cost 278,596 247,351 140,033 117,722 83,116 54,961 38,677 38.94%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -297.65 -11,855.10 -719.10 -762.37 -1,214.29 -400.92 -330.17 -1.71%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -1.92 -2.43 -1.34 -1.21 -0.91 -0.58 -0.48 25.97%
EPS Diluted -1.92 -2.43 -1.34 -1.21 -0.91 -0.58 -0.48 25.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.